Related Experiment Video
Updated: May 3, 2026
Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Mammalian SIRT2 inhibits keratin 19 expression and is a tumor suppressor in skin
Mei Ming1, Lei Qiang, Baozhong Zhao
1Section of Dermatology, Department of Medicine, University of Chicago, Chicago, IL, USA.
Abstract:
SIRT2 is a member of the mammalian sirtuin family (SIRT1-7). As compared with other sirtuins, SIRT2 is found primarily in the cytoplasm. It regulates multiple physiological processes. However, the precise role of SIRT2 in skin cancer remains unclear. Here, we show that SIRT2 is downregulated in human skin cancer as compared with normal skin. SIRT2 deletion increases tumor growth in mice. SIRT2 knockdown upregulates the stem cell marker Keratin 19 (K19) in keratinocytes. In mice, SIRT2 deletion up-regulates K19 and K15 while it down-regulates the differentiation marker Loricrin in both normal skin and tumors. In skin tumors but not normal skin, SIRT2 deletion up-regulates the stem cell marker CD34 and increases the number of Ki67-positive cells. These findings indicate that SIRT2 is a tumor suppressor in the skin. Our findings add new insights into the role of SIRT2 in the molecular pathogenesis of skin cancer.
Insights
Sirtuin 2 (SIRT2) acts as a tumor suppressor in skin cancer. Its downregulation in skin cancer promotes tumor growth by upregulating stem cell markers and inhibiting differentiation.
Area of Science:
- Molecular biology
- Oncology
- Dermatology
Background:
- Sirtuin 2 (SIRT2) is a cytoplasmic protein regulating physiological processes, but its role in skin cancer is not well understood.
- Previous research has not fully elucidated the specific function of SIRT2 in the context of skin carcinogenesis.
Discussion:
- SIRT2 downregulation is observed in human skin cancer, contrasting with normal skin.
- SIRT2 deficiency in mice leads to increased tumor growth and altered expression of key skin markers.
- The study investigates the impact of SIRT2 on stem cell markers (K19, K15, CD34) and differentiation markers (Loricrin) in skin keratinocytes and tumors.
Key Insights:
- SIRT2 acts as a tumor suppressor in the skin.
- SIRT2 deletion upregulates stem cell markers (K19, K15, CD34) and downregulates differentiation markers (Loricrin).
- SIRT2 loss increases proliferation (Ki67-positive cells) in skin tumors.
Outlook:
- Further research into SIRT2's regulatory mechanisms in skin cancer pathogenesis is warranted.
- Targeting SIRT2 could offer novel therapeutic strategies for skin cancer treatment.
- Understanding SIRT2's role may provide new insights into the molecular basis of skin tumor development.
Related Concept Videos
02:23Abnormal Proliferation
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:12Loss of Tumor Suppressor Gene Functions
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...